Bioresorbable zinc stent with ultra-thin center struts attenuates stent jail in porcine femoral artery bifurcations

References

• Briguori C, Sarais C, Pagnotta P, et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll of Cardiol. 2002;40:403–409.
   PubMed Web of Science ®Google Scholar
• Elwany M, Di Palma G, Cortese B. Fracture with the newer bioresorbable vascular scaffolds. Catheter Cardiovasc Interv. 2017;90:582–583.
   PubMed Web of Science ®Google Scholar
• Foin N, Lee R, Bourantas C, et al. Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: insights from in vitro expansion in a coronary artery lesion model. EuroIntervention. 2016;12:834–844.
   PubMed Web of Science ®Google Scholar
• Diletti R, Tchetche D, Barbato E, et al. Bioresorbable scaffolds for treatment of coronary bifurcation lesions: critical appraisal and future perspectives. Catheter Cardiovasc Interv. 2016;88:397–406.
   PubMed Web of Science ®Google Scholar
• Steinvil A, Rogers T, Torguson R, et al. Overview of the 2016 U.S. JACC Cardiovasc Interv. 2016;9:1757–1764.
   PubMed Web of Science ®Google Scholar
• Yamawaki M, Hirano K, Nakano M, et al. Deployment of self-expandable stents for complex proximal superficial femoral artery lesions involving the femoral bifurcation with or without jailed deep femoral artery. Cathet Cardiovasc Intervent. 2013;81:1031–1041.
   PubMed Web of Science ®Google Scholar
• Siracuse JJ, Van Orden K, Kalish JA, et al.; Vascular Quality Initiative. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg. 2017;65:1039–1046.
   PubMed Web of Science ®Google Scholar
• [Ansel G. Keep out of jail: the reason to limit stent usage for the common femoral artery bifurcation. Catheter Cardiovasc Interv. 2013;81:1042.
   PubMed Web of Science ®Google Scholar
• Hehrlein C, Schorch B, Kress N, et al. Zn-alloy provides a novel platform for mechanically stable bioresorbable vascular stents. Plos One. 2019;14:e0209111.
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.
   PubMed Web of Science ®Google Scholar
• Murphy JG, Schwartz RS, Edwards WD, et al. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents. Circulation. 1992;86:1596–1604.
   PubMed Web of Science ®Google Scholar
• Werner M, Micari A, Cioppa A, et al. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study. JACC Cardiovasc Interv. 2014;7:305–312.
   PubMed Web of Science ®Google Scholar
• Kwon O, Ahn JM, Kang DY, et al. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea. Korean J Intern Med. 2018;33:922–932.
   PubMed Web of Science ®Google Scholar
• Adjedj J, Picard F, Mogi S, et al. In vitro flow and optical coherence tomography comparison of two bailout techniques after failed provisional stenting for bifurcation percutaneous coronary interventions. Catheter Cardiovasc Interv. 2019;93:E8–E16.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang D, Yin D, et al. Can “true bifurcation lesion” actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: a retrospective analysis of 1,200 consecutive bifurcation lesions in a single center. Cathet Cardiovasc Intervent. 2016;87:554–563.
   PubMed Web of Science ®Google Scholar
• Généreux P, Kumsars I, Lesiak M, et al. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. J Am Coll Cardiol. 2015;65:533–543.
   PubMed Web of Science ®Google Scholar
• Naganuma T, Colombo A, Lesiak M, et al. Bioresorbable vascular scaffold use for coronary bifurcation lesions: a substudy from GHOST EU registry. Catheter Cardiovasc Interv. 2017;89:47–56.
   PubMed Web of Science ®Google Scholar
• Serruys PW, Chevalier B, Sotomi Y, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet. 2016;388:2479–2491.
   PubMed Web of Science ®Google Scholar
• Suwannasom P, Sotomi Y, Asano T, et al. Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study. EuroIntervention. 2017;12:e2244–e2252.
   PubMed Web of Science ®Google Scholar
• Haude M, Ince H, Abizaid A, et al. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. Lancet. 2016;387:31–39.
   PubMed Web of Science ®Google Scholar
• Capranzano P, Capodanno D, Brugaletta S, et al. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry. Catheter Cardiovasc Interv. 2018;91:444–453.
   PubMed Web of Science ®Google Scholar
• Giblett JP, Brown AJ, Hoole SP, et al. Early disarticulation of a bioresorbable vascular scaffold: an underreported consequence of repeat imaging. Cardiovasc Interv Ther. 2018;33:175–177.
   PubMed Web of Science ®Google Scholar
• Campos CM, Lemos PA. Bioresorbable vascular scaffolds: novel devices, novel interpretations, and novel interventions strategies. Catheter Cardiovasc Interv. 2014;84:46–47.
   PubMed Web of Science ®Google Scholar
• Conway C. Coronary stent fracture: clinical evidence vs. the testing paradigm. Cardiovasc Eng Technol. 2018;9:752–760.
   PubMed Web of Science ®Google Scholar
• Kapnisis K, Constantinides G, Georgiou H, et al. Multi-scale mechanical investigation of stainless steel and cobalt-chromium stents. J Mech Behav Biomed Mater. 2014;40:240–251.
   PubMed Web of Science ®Google Scholar
• Marynissen T, McCutcheon K, Bennett J. Early collapse causing stenosis in a resorbable magnesium scaffold. Catheter Cardiovasc Interv. 2018;92:310–312.
   PubMed Web of Science ®Google Scholar
• Bowen PK, Shearier ER, Zhao S, et al. Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys. Adv Healthc Mater. 2016;5:1121–1140.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang C, Liu C, et al. Evolution of the degradation mechanism of pure zinc stent in the one-year study of rabbit abdominal aorta model. Biomaterials. 2017;145:92–105.
   PubMed Web of Science ®Google Scholar